Pharis Mohideen, CMO at Tempest Therapeutics, holds 82.19K shares in DBV Technologies SA - American (Ticker: DBVT), holds 7.44K shares in Tempest Therapeutics (Ticker: TPST). Most recently, Pharis Mohideen Sold ― shares of DBV Technologies SA - American on Dec 19, 2023 for an estimated value of 3.91K.